Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre studyWalter Reinisch, Fabio Cataldi, Michelle Hinz et al.|Gut|2015Cited by 157
IMA-638 in Active Ulcerative Colitis: Efficacy and Safety from a Phase IIa Multicenter StudySunil Khurana, Walter Reinisch, Julián Panés et al.|The American Journal of Gastroenterology|2013Cited by 0
IMA-638 in Active Ulcerative Colitis from a Phase IIa Multicenter Study: Correlation between Fecal Calprotectin Levels and Clinical ActivitySunil Khurana, Walter Reinisch, Julián Panés et al.|The American Journal of Gastroenterology|2013Cited by 0